ABC News reports a 17.5% increase in asthma-related hospitalization in the three months after Flovent was discontinued and a 24.1% increase in the next three to six months. Other pharma news covers ...

It was analyzed by two teams at EPIC Research, who came to similar conclusions. These findings have not gone through ... Insurance companies have recently limited the asthma medications they cover, ...

Weight-loss and diabetes drugs like Ozempic, Wegovy, Mounjaro or Zepbound appear to help people battle alcoholism and opioid addiction, a new study finds. People taking this class of drugs ...

One of the most prominent medical developments in recent years has been the emergence of a class of drugs called glucagon-like peptide-1 receptor agonists (GLP-1 RAs). The best known of these ...

Those who took Ozempic or a similar drug had a 40% lower chance of overdosing on opioids and a 50% lower chance of getting drunk compared to those who didn't take the medication, the study found.

Ozempic is one of several medications, called glucagon-like peptide-1 receptor agonists or GLP-1 RAs, that are prescribed to treat diabetes, obesity, and other weight-related medical conditions.

The Biden administration has reformed Medicare, gone after bogus drug patents and pushed pharmaceutical companies to reduce inhaler costs for patients. “Climate-friendly inhalers” could jeopardize ...

A national survey found that 75% of new hemodialysis patients and 60% of patients already receiving hemodialysis therapy were taking antihypertensive drugs. [20] Similar data about ...

Reading from a prepared affidavit, she said Duterte phoned her in May 2016 and instructed her to find him a PNP officer who would lead the government’s drug war similar to the “Davao model.” ...

Share on Pinterest Are GLP-1 drugs good for brain health? Accumulating evidence seems to suggest so. Image credit: Popartic/Getty Images. GLP-1 drugs such as Wegovy and Ozempic (semaglutide ...

Le Merrer and Becker are now testing MB204 in another chronic Rett syndrome model (Mecp2) and are looking forward to seeing how it performs ‘head-to-head’ against the approved drug Trofinetide ...